Cargando…
Bleomycin Sclerotherapy in Massive Macrocystic Lymphatic Malformation: Minimal Complications with Maximum Results
INTRODUCTION: Cystic lymphangioma (CL) is a multiloculated congenital malformation of the lymphatic system occurring in approximately 1 in 6,000–12,000 births, and it mostly presents at birth. The CL is of a variable size and it can be found at any age and in any part of the body. This study was car...
Autores principales: | Bhatnagar, Ankur, Neyaz, Zafar, Singh, Brajesh, Mishra, Ashwani, Yusuf, Upadyayaya, Vijai Datta, Kumar, Basant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061645/ https://www.ncbi.nlm.nih.gov/pubmed/33911413 http://dx.doi.org/10.4103/JCAS.JCAS_108_20 |
Ejemplares similares
-
Management of macrocystic lymphatic malformation at uncommon site with aqueous bleomycin sclerotherapy
por: Bhatnagar, Ankur, et al.
Publicado: (2020) -
Is multiple session of intralesional bleomycin mandatory for complete resolution of macrocystic lymphatic malformation?
por: Upadhyaya, Vijai Datta, et al.
Publicado: (2018) -
Aqueous intralesional bleomycin sclerotherapy in lymphatic malformation: Our experience with children and adult
por: Bhatnagar, Ankur, et al.
Publicado: (2017) -
Results of Injection Sclerotherapy with Bleomycin in Pediatric Lymphatic Malformations
por: Kumar, Vipan, et al.
Publicado: (2021) -
Giant Macrocystic Lymphatic Malformation in a Neonate
por: Uresti, Mónica Andrea Pinzón, et al.
Publicado: (2017)